These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8826402)

  • 21. Detection of vancomycin-resistant enterococci colonization in a children's hospital.
    Christenson JC; Korgenski EK; Jenkins E; Daly JA
    Am J Infect Control; 1998 Dec; 26(6):569-71. PubMed ID: 9836840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of an outbreak of vancomycin-resistant Enterococcus faecium by random amplified polymorphic DNA (RAPD) assay.
    Issack MI; Power EG; French GL
    J Hosp Infect; 1996 Jul; 33(3):191-200. PubMed ID: 8827505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical Infection Society position on vancomycin-resistant Enterococcus.
    Davis JM; Huycke MM; Wells CL; Bohnen JM; Gadaleta D; Fichtl RE; Barie PS
    Arch Surg; 1996 Oct; 131(10):1061-8. PubMed ID: 8857903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sudden increase of vancomycin-resistant enterococcal infections in a Korean tertiary care hospital: possible consequences of increased use of oral vancomycin.
    Shin JW; Yong D; Kim MS; Chang KH; Lee K; Kim JM; Chong Y
    J Infect Chemother; 2003 Mar; 9(1):62-7; discussion 104-5. PubMed ID: 12673410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment options for vancomycin-resistant enterococcal infections.
    Linden PK
    Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology and control of vancomycin-resistant enterococci (VRE) in a renal unit.
    Brown AR; Amyes SG; Paton R; Plant WD; Stevenson GM; Winney RJ; Miles RS
    J Hosp Infect; 1998 Oct; 40(2):115-24. PubMed ID: 9819690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC).
    MMWR Recomm Rep; 1995 Sep; 44(RR-12):1-13. PubMed ID: 7565541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vancomycin-resistant enterococci.
    Rubinstein E; Keynan Y
    Crit Care Clin; 2013 Oct; 29(4):841-52. PubMed ID: 24094380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of subclinical transmission of vancomycin-resistant enterococcus within an intensive care unit in Taiwan.
    Lee SC; Lee CW; Shih TC; See LC; Chu CM; Liu YC
    J Microbiol Immunol Infect; 2016 Oct; 49(5):749-759. PubMed ID: 27156242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Combination Antimicrobial Therapy for Vancomycin-Resistant Enterococcus faecium Infections: Review of the Current Evidence.
    Yim J; Smith JR; Rybak MJ
    Pharmacotherapy; 2017 May; 37(5):579-592. PubMed ID: 28273381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vancomycin-resistant Enterococcus in liver transplant patients.
    Orloff SL; Busch AM; Olyaei AJ; Corless CL; Benner KG; Flora KD; Rosen HR; Rabkin JM
    Am J Surg; 1999 May; 177(5):418-22. PubMed ID: 10365883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci.
    Zaas AK; Song X; Tucker P; Perl TM
    Clin Infect Dis; 2002 Nov; 35(10):1139-46. PubMed ID: 12410472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence, outcome and risk factor associated with vancomycin-resistant Enterococcus faecalis and Enterococcus faecium at a Tertiary Care Hospital in Northern India.
    Tripathi A; Shukla SK; Singh A; Prasad KN
    Indian J Med Microbiol; 2016; 34(1):38-45. PubMed ID: 26776117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Observations on the risk of resistance with the extended use of vancomycin.
    McManus AT; Goodwin CW; Pruitt BA
    Arch Surg; 1998 Nov; 133(11):1207-11. PubMed ID: 9820352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and epidemiological study of vancomycin-resistant Enterococcus faecium from patients of a haematological unit in Poland.
    Samet A; Bronk M; Hellmann A; Kur J
    J Hosp Infect; 1999 Feb; 41(2):137-43. PubMed ID: 10063476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Healthcare-associated vancomycin resistant Enterococcus faecium infections in the Mansoura University Hospitals intensive care units, Egypt.
    Moemen D; Tawfeek D; Badawy W
    Braz J Microbiol; 2015; 46(3):777-83. PubMed ID: 26413060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural history of colonization with vancomycin-resistant Enterococcus faecium.
    Montecalvo MA; de Lencastre H; Carraher M; Gedris C; Chung M; VanHorn K; Wormser GP
    Infect Control Hosp Epidemiol; 1995 Dec; 16(12):680-5. PubMed ID: 8683085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vancomycin-resistant enterococci (VRE) colonization of high-risk patients in tertiary care Canadian hospitals. Canadian VRE Surveillance Group.
    Karlowsky JA; Zhanel GG; Hoban DJ
    Diagn Microbiol Infect Dis; 1999 Sep; 35(1):1-7. PubMed ID: 10529874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of transposon Tn5482 in the epidemiology of vancomycin-resistant Enterococcus faecium in the pediatric oncology unit of a New York City Hospital.
    de Lencastre H; Brown AE; Chung M; Armstrong D; Tomasz A
    Microb Drug Resist; 1999; 5(2):113-29. PubMed ID: 10432272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk.
    Worth LJ; Thursky KA; Seymour JF; Slavin MA
    Eur J Haematol; 2007 Sep; 79(3):226-33. PubMed ID: 17655696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.